Skip to content
Jul 20 2016

Management of Cirrhosis – The Basics

Morning Report

cirrhosis-s1-facts

Teaching Point

  • Common etiologies
    • Alcohol
    • Hepatitis C and B
    • NAFLD
  • Complications
    • Ascites: spironolactone 100mg/lasix 40mg
    • SBP: ceftriaxone 2gm IV q24h
    • Hepatic encephalopathy: lactulose, neomycin/rifaximin
Read more
Jul 13 2016

Intern Case Conference – Acute Coronary Syndrome

Morning Report

Here is the powerpoint for today's intern case conference on ACS: InternReport.ACS Guidelines: AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction Further Reading: Mechanisms of ACS and their…

Read more
Jul 12 2016

Drug-Induced Liver Injury

Morning Report

Highlighted_Liver_crop

Thank you Dr. Reynolds for an excellent presentation on drug-induced liver injury

Teaching Points

  • Patterns of abnormal LFTS
    • Hepatocellular: high AST/ALT w/mild elevation in alk phos
    • Cholestatic: High alk phos w/ mild AST/ALT
  • Causes of hepatocellular injurry
    • Alcohol: AST elevation greater than ALT
    • Viral: ALT elevation greater than AST
    • NAFLD/NASH: AST to ALT ratio typically 1
    • Toxins: NSAIDS, abx, statins, anti-epileptic drugs
    • Hereditary/autoimmune: hemochromatosis, autoimmune hepatitis, alpha-1-antitrypsin deficiency, Wilson’s disease
    • Shock: high elevations in AST/ALT
    • Non-hepatic causes: muscle disorders, thyroid issues, celiac disease, adrenal insufficiency, anorexia
Read more
Jul 08 2016

Atrial Fibrillation

Morning Report

Thank you Dr. Feng for an excellent presentation on the management of atrial fibrillation in the setting of acute de-compensated heart failure

Teaching Points

  • Important components of management: hemodynamic stability, rate control, anti-coagulation
  • Rate control agents: beta blockers, calcium channel blockers (not preferred in HF), digoxin and amiodarone (also an anti-arrhythmic)
  • Antiarrhythmics for afib are Class IC or III
    • IC: flecainide, propafeonone
    • III: amiodarone, dronedarone, sotalol, dofetilide
  • Anti-coagulation: indicated if CHADSVASc ≥ 2 (warfarin or newer agents, ie apixaban or rivaroxaban)
Read more
Jul 07 2016

Intern Case Conference 7.6.16

Morning Report

Here is the power point from today’s case conference on the diagnosis and management of Community Acquired Pneumonia. Intern Report 7.6.16

Read more
Jul 05 2016

Granulomatosis with Polyangiitis Glomerulonephritis

Morning Report

Thank you Dr. Jang for an excellent presentation on granulomatosis with polyangiitis presenting as lower extremity edema from renal involvement. Teaching Points: GPA can involve multiple organs including nasal ulcers, cartiglage destruction, tracheal stenosis, alveolar hemorrhage, glomerulonephritis, leukoclastic angiitis Diagnosis…

Read more
Jun 17 2016

Ischemic Stroke From Infective Endocarditis

Morning Report

Thank you Dr. Tu for an excellent presentation of ischemic stroke due to septic emboli from infective endocarditis Teaching Points: CNS complications of infective endocarditis can occur in 20-40% patients Etiology: occlusion of cerebral arteries by septic emboli, cerebral hemorrhage, meningitis,…

Read more
Jun 15 2016

Progression of Myocardial Infarction

Morning Report

Thank you Dr. Janoian for a great presentation on the progression of myocardial infarction. Teaching Points: pathologic outcomes of MI: arrhythmia, ischemic cardiomyopathy with or without cardiogenic shock, mechanical dysfunction/complications, pericarditis mechanical complications: papillary muscle rupture, ventricular free wall rupture,…

Read more
Jun 08 2016

Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia

Morning Report

ARVD

Thank you Dr. Layoun for an excellent presentation on arrhythmogenic right ventricular cardiomyopathy/dysplasia

Teaching Points:

  • ARVD is a genetic cardiomyopathy with mutations in desmoglein-2, desmoplakin, desmocollin-2, plakophilin, etc
  • Characterized by life-threatening ventricular arrhythmias (monomorphic VT)
  • ECG: QRS prolongation (in right precordial leads), RBBB morphology, Epsilon Wave (distinct wave between QRS and T waves, seen in precordial leads, V1 is the best spot)
  • Treatment: refrain from high intensity exercise, low dose beta-blocker, ICD for secondary prophylaxis in patients with history of VT or VF
Read more
Back To Top
Login
Log in below to access learning modules.
Forgot Password
Enter your email address or username and we’ll send you instructions to reset your password.